CCRN 📈 Cross Country Healthcare - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2274831047

CCRN: Healthcare, Staffing, Consulting, Recruitment, Nursing, Physicians, Services

Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services. It also offers staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term contract assignments, as well as workforce solutions, including MSP, VMS, in- home care, education healthcare, RPO, project management, and other outsourcing and consultative services. This segment provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. It serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and other healthcare providers under the Cross Country brand. Its Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand on temporary assignments. It serves various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida. Web URL: https://www.crosscountry.com

Additional Sources for CCRN Stock

CCRN Stock Overview

Market Cap in USD 354m
Sector Healthcare
Industry Medical Care Facilities
GiC Sub-Industry Health Care Services
IPO / Inception 2001-10-25

CCRN Stock Ratings

Growth 5y 19.1%
Fundamental -6.65%
Dividend -
Rel. Strength Industry -461
Analysts 3.63/5
Fair Price Momentum 16.51 USD
Fair Price DCF 81.17 USD

CCRN Dividends

No Dividends Paid

CCRN Growth Ratios

Growth Correlation 3m 4.1%
Growth Correlation 12m -76%
Growth Correlation 5y 47.2%
CAGR 5y 8.98%
CAGR/Mean DD 5y 0.28
Sharpe Ratio 12m -0.02
Alpha -33.57
Beta 0.39
Volatility 52.95%
Current Volume 1011.1k
Average Volume 20d 1472.6k
What is the price of CCRN stocks?
As of December 22, 2024, the stock is trading at USD 17.91 with a total of 1,011,089 shares traded.
Over the past week, the price has changed by -0.83%, over one month by +75.42%, over three months by +23.26% and over the past year by -18.55%.
Is Cross Country Healthcare a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Cross Country Healthcare is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -6.65 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CCRN as of December 2024 is 16.51. This means that CCRN is currently overvalued and has a potential downside of -7.82%.
Is CCRN a buy, sell or hold?
Cross Country Healthcare has received a consensus analysts rating of 3.63. Therefor, it is recommend to hold CCRN.
  • Strong Buy: 2
  • Buy: 1
  • Hold: 5
  • Sell: 0
  • Strong Sell: 0
What are the forecast for CCRN stock price target?
According to ValueRays Forecast Model, CCRN Cross Country Healthcare will be worth about 18 in December 2025. The stock is currently trading at 17.91. This means that the stock has a potential upside of +0.56%.
Issuer Forecast Upside
Wallstreet Target Price 15.6 -12.9%
Analysts Target Price 27.8 55.2%
ValueRay Target Price 18 0.6%